Loading...
XKRX123690
Market cap68mUSD
Dec 24, Last price  
6,230.00KRW
1D
0.97%
1Q
-16.71%
Jan 2017
-50.75%
IPO
57.72%
Name

Hankook Cosmetics Co Ltd

Chart & Performance

D1W1MN
XKRX:123690 chart
P/E
28.51
P/S
1.27
EPS
218.48
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
-12.55%
Revenues
78.71b
+19.18%
31,981,857,00070,283,225,46073,399,936,13068,668,703,13076,333,756,99098,446,610,260160,754,823,700151,256,003,800153,882,570,610131,196,339,33072,498,592,51066,965,810,09066,046,677,15078,712,916,916
Net income
3.51b
+739.56%
-17,201,973,000-16,414,178,000-19,936,017,000-16,176,046,00026,331,755,000-9,060,582,00014,617,694,0004,028,516,000-7,746,017,000-17,224,383,050-7,573,797,760-7,281,617,880418,118,7103,510,376,990
CFO
4.86b
+58.68%
4,919,940,000-18,839,864,450-13,441,382,730-9,615,418,990-7,433,358,700-17,052,655,65018,157,489,570-8,159,751,150-1,293,286,3005,351,702,410-805,862,270-9,242,444,8003,062,605,4404,859,874,170

Profile

Hankook Cosmetics Co., Ltd. produces and sells cosmetics in South Korea and internationally. It offers its products under the Sansim, Hyoum, Ossion, Jutanhak, Secret Nature, Calli, GENERTE, A3F[on], Temptation, CONTINUE, Chess The Classic, CLASSYGIRL, Beautri, BEAUTENIQUE, Dr Medix, and Parapam brands. The company was founded in 1961 and is based in Seoul, South Korea.
URL
https://www.ihkcos.com/
IPO date
Jun 01, 2010
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
78,712,917
19.18%
66,046,677
-1.37%
66,965,810
-7.63%
Cost of revenue
62,737,468
52,878,705
54,703,234
Unusual Expense (Income)
NOPBT
15,975,449
13,167,973
12,262,576
NOPBT Margin
20.30%
19.94%
18.31%
Operating Taxes
(246,321)
(2,305,527)
3,164,189
Tax Rate
25.80%
NOPAT
16,221,770
15,473,499
9,098,387
Net income
3,510,377
739.56%
418,119
-105.74%
(7,281,618)
-3.86%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
3,472,387
3,748,476
6,838,814
Long-term debt
1,817,459
3,768,304
5,617,382
Deferred revenue
305,576
371,660
551,500
Other long-term liabilities
614,619
455,998
(270)
Net debt
(14,237,651)
(11,474,919)
2,346,535
Cash flow
Cash from operating activities
4,859,874
3,062,605
(9,242,445)
CAPEX
(910,656)
(962,441)
(526,663)
Cash from investing activities
(731,883)
7,318,652
(2,580,214)
Cash from financing activities
(1,164,090)
(4,132,720)
(4,051,241)
FCF
17,636,821
18,699,867
14,708,974
Balance
Cash
15,067,597
12,120,424
12,938,786
Long term investments
4,459,900
6,871,275
(2,829,125)
Excess cash
15,591,851
15,689,365
6,761,370
Stockholders' equity
9,273,934
6,314,977
5,873,830
Invested Capital
20,963,307
21,984,237
25,527,787
ROIC
75.54%
65.14%
32.42%
ROCE
52.83%
46.53%
38.49%
EV
Common stock shares outstanding
16,067
16,067
16,067
Price
6,350.00
-21.99%
8,140.00
-6.54%
8,710.00
-31.69%
Market cap
102,025,894
-21.99%
130,785,950
-6.54%
139,944,180
-31.69%
EV
87,604,648
119,090,639
142,262,126
EBITDA
18,100,222
16,599,273
17,514,452
EV/EBITDA
4.84
7.17
8.12
Interest
251,229
379,347
561,119
Interest/NOPBT
1.57%
2.88%
4.58%